SCHEMBL7657290

SCHEMBL7657290

CCOC(=O)c1ccccc1-c1ccccc1C(=O)Nc1ccc(C(N)=NOC(=O)OC(C)(C)C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.50
ALDH1A1 P00352 6/20 0.50
RAB9A P51151 5/20 0.50
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
NPC1 O15118 4/20 0.50
GAA P10253 3/20 0.50
MAPT P10636 3/20 0.42
MAPK1 P28482 3/20 0.42
LMNA P02545 1/20 0.41
KDM4E B2RXH2 2/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
MAOA P21397 1/20 0.41
TSHR P16473 1/20 0.40
CASP3 P42574 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656320 0.90 GAA (0.43) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7656726 0.88 F3 (0.57)
SCHEMBL7660125 0.87 CYP2C9 (0.52) MEN1KMT2AGAALMNAPOLB
SCHEMBL7658461 0.82 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7662346 0.77 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7663254 0.75 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7656495 0.75 F10 (0.57)
SCHEMBL7654193 0.74 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7661471 0.74 CYP3A4 (0.53) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL10173004 0.71 TNF (0.57) SMN1; SMN2RAB9AKMT2ANPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed